Cellular and molecular biology of small cell lung cancer: an overview

Por Karachaliou, Niki, Pilotto, Sara, Lazzari, Chiara, Bria, Emilio, de Marinis, Filippo, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2016)

Homeodomain Interacting Protein Kinase 2 Activation Compromises Endothelial Cell Response to Laminar Flow: Protective Role of p21(waf1,cip1,sdi1)

Por Mattiussi, Stefania, Lazzari, Chiara, Truffa, Silvia, Antonini, Annalisa, Soddu, Silvia, Capogrossi, Maurizio C., Gaetano, Carlo
Publicado em 2009

Targeted drugs in small-cell lung cancer

Por Santarpia, Mariacarmela, Daffinà, Maria Grazia, Karachaliou, Niki, González-Cao, Maria, Lazzari, Chiara, Altavilla, Giuseppe, Rosell, Rafael
Publicado no Transl Lung Cancer Res (2016)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

Por Giovannini, Monica, Gregorc, Vanesa, Belli, Carmen, Roca, Elisa, Lazzari, Chiara, Viganò, Maria Grazia, Serafico, Anna, Villa, Eugenio
Publicado em 2009

Personalized treatment in advanced ALK-positive non-small cell lung cancer: from bench to clinical practice

Por Passaro, Antonio, Lazzari, Chiara, Karachaliou, Niki, Spitaleri, Gianluca, Pochesci, Alessia, Catania, Chiara, Rosell, Rafael, de Marinis, Filippo
Publicado no Onco Targets Ther (2016)

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

Por Lazzari, Chiara, Bulotta, Alessandra, Ducceschi, Monika, Viganò, Maria Grazia, Brioschi, Elena, Corti, Francesca, Gianni, Luca, Gregorc, Vanesa
Publicado no Front Med (Lausanne) (2017)

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)

Por Spitaleri, Gianluca, Biffi, Roberto, Barberis, Massimo, Fumagalli, Caterina, Toffalorio, Francesca, Catania, Chiara, Noberasco, Cristina, Lazzari, Chiara, de Marinis, Filippo, De Pas, Tommaso
Publicado no Onco Targets Ther (2015)

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E

Por Catania, Chiara, Conforti, Fabio, Spitaleri, Gianluca, Barberis, Massimo, Preda, Lorenzo, Noberasco, Cristina, Lazzari, Chiara, Toffalorio, Francesca, de Marinis, Filippo, Manzotti, Michela, De Pas, Tommaso Martino
Publicado em 2014

Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib

Por Gainor, Justin F., Tan, Daniel S.W., De Pas, Tomasso, Solomon, Benjamin J., Ahmad, Aziah, Lazzari, Chiara, de Marinis, Filippo, Spitaleri, Gianluca, Schultz, Katherine, Friboulet, Luc, Yeap, Beow Y., Engleman, Jeffrey A., Shaw, Alice T.
Publicado no Clin Cancer Res (2015)